JNJ edges out AZN following Q2 results with raised guidance, stronger estimate revisions and a more attractive valuation.

Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.

J.P. Morgan Asset Management Chief Market Strategist for the Americas Gabriela Santos said that she would allocate $7,000 to ...

The Trump administration has proposed a pilot initiative to address controversy over the 340B drug discount program.

Teva Pharmaceutical Industries TEVA reported second-quarter 2025 adjusted earnings of 66 cents per share, which beat the ...

Shares of European pharmaceutical companies sold off on Friday after President Donald Trump issued letters to 17 companies, ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

These four Dividend Aristocrats are Buy-rated sector leaders with yields above 3%. Passive income investors can buy and hold ...

Find the latest Teva Pharmaceutical Industries Limited (TEVA) stock quote, history, news and other vital information to help you with your stock trading and investing.

President Donald Trump sent letters to 17 leading pharmaceutical manufacturers, including Eli Lilly (NYSE:LLY), Pfizer ...

Thanks to its international presence, […] JNJ jumps over 6% on Q2 earnings beat and full ... J&J announced in late 2021 that it was splitting its consumer health division from the pharmaceutical and ...

The White House announced on Thursday that President Trump sent 17 major pharmaceutical companies letters delineating the ...